Jaret L. Davis is the Co-Managing Shareholder of the Miami office of Greenberg Traurig, P.A. and a member of the firm’s global Executive Committee. He oversees approximately 170 attorneys and 200 business staff based in the firm’s founding office in Miami, Florida USA and focuses his corporate and securities practice on domestic and cross-border mergers and acquisitions, capital markets transactions, and large financings.
For over a decade, Jaret has led the efforts of the Miami office and played a key role in the firm’s global efforts to be a dominant player in the technology industry. The vast majority of Jaret’s clients are technology players, ranging from information technology companies, to life sciences/biotech companies, to companies focusing on renewable energy sources. Under Jaret’s leadership, the Miami office has been a thought leader in representing angel investors, venture capital firms, growth equity funds, as well as various technology companies along all intervals of the life cycle, from startup to multi-billion dollar publicly-traded companies. He routinely provides representation to publicly traded clients having an aggregate market capitalization of over $20 billion.
Jaret’s notable representations in the IT space include him serving as lead shareholder of the team that represented Medina Capital in its $3 billion joint venture with global private equity fund BC Partners, which consisted of the acquisition of a portfolio of 57 data centers across the globe and suite of cybersecurity and data analytics companies. In addition, he served as lead shareholder of the 40+ attorney legal team representing Terremark Worldwide, Inc., a Nasdaq-listed provider of IT infrastructure, in connection with its acquisition for $2 billion by Verizon Communications, Inc. At the time of its closing, the Terremark-Verizon transaction ranked as both the largest pairing of a telco and a colocation provider and the largest transaction in the cloud computing space as well as Verizon's largest acquisition since its acquisition of MCI in 2005.
Jaret’s notable representations in the life sciences/healthcare space include him serving as lead shareholder of the team that represented Exactech, Inc., a Nasdaq-listed producer of orthopedic solutions, in connection with its $737 million acquisition by global private equity fund, TPG Capital, and serving as a primary shareholder representing Metropolitan Health Networks, Inc., a New York Stock Exchange listed health care provider, in its $850 million sale to Humana, Inc.
In addition to his practice, Jaret serves in a number of civic capacities that allow him to leverage his professional interests to assist the South Florida community. He currently serves as Chairman of the Board of Directors of Nicklaus Children’s Hospital, one of the largest health systems in the State of Florida and a thought leader at leveraging digital health solutions, and serves as a co-founder and General Counsel of the eMerge Americas global technology conference. He recently served as Chair of the Miami-Dade Beacon Council, the Official Economic Development Partnership for Miami-Dade County in which capacity he led Miami’s efforts in bidding to obtain Amazon’s HQ2 headquarters resulting in Miami being one of the finalists in the process.
In 2018, the Daily Business Review, a division of the ALM Media, selected Jaret to be the recipient of its 2018 “Attorney of the Year” Award in recognition of his role in facilitating recent significant transactions in both IT and life sciences/health care as well as his corporate and civic leadership within those industries. He has been recognized by a number of other publications, including Super Lawyers, the M&A Advisor, which selected him for its 2010 "40 Under 40" list, the National Law Journal, which selected him for its 2011 "Minority 40 Under 40" list, the Daily Business Review, which designated him "Top Dealmaker of the Year" in both 2010 and 2012 and the South Florida Business Journal, which selected him for its Key Partners Award.
- Angel investors
- Venture Capital Funds
- Growth Equity Funds
- Series Seed, Series A, Series B investments
- Software and technology license agreements
- Electronic commerce
- Intellectual Property matters
- Software as service agreements
- Consulting services
- Colocation agreements
- Managed hosting services
- Development agreements
Life Sciences/Biotech/Healthcare Transactions
- Medical device manufacturers and distributors
- Pharmaceutical companies
- Digital health technology providers
- Physician practice groups
- Behavioral health/Substance abuse treatment centers
- Ambulatory Surgical Centers
- Assisted living facilities
- Public offerings
- Private placements
- PIPES and registered directs
- 144A offerings
- Equity and debt offerings
- Underwriter representations
Mergers and Acquisitions
- Strategic business combinations
- Sale of control transactions
- Going-private transactions
- Corporate takeover contests and defense
- Section 363/prepackaged bankruptcy acquisitions
- Syndicated debt transactions
- Secured debt offerings
- DIP financings in bankruptcy proceedings